News room
Technophage featured in ‘The Business Year Portugal 2022’
This year Technophage has been featured in the Portuguese edition of The Business Year. The publication was based on more than 130 face-to-face...
Technophage is hiring a Financial Controller
TechnoPhage is currently looking for a new Financial Controller with a degree in Economics, Finance or related area, and at least 7 years of...
TechnoPhage S.A. announces spin-off of T-Oncology AG
TechnoPhage announced the spin-off of T-Oncology AG, which will focus on the development of Antibody Drug Conjugates (ADCs), based on the...
Technophage has been listed as ‘One of FT1000’s Fastest-Growing Companies in Europe’
The continued growth of Technophage from a small biotech into a clinical-stage biopharma has resulted in the company making the Financial Times'...
Technophage granted with the ‘COTEC Innovative Status 2022′
Technophage is proud to announce that it has recently been granted with the ‘COTEC Innovative Status 2022’. COTEC Portugal is the main Portuguese...